Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 4 studies | 24% ± 10% | |
| GABAergic neuron | 4 studies | 39% ± 16% | |
| glutamatergic neuron | 4 studies | 49% ± 20% | |
| oligodendrocyte | 4 studies | 17% ± 3% | |
| interneuron | 3 studies | 41% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 37% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2481.35 | 245 / 245 | 100% | 9.46 | 501 / 502 |
| thymus | 100% | 2513.15 | 653 / 653 | 99% | 17.10 | 601 / 605 |
| kidney | 100% | 1659.75 | 89 / 89 | 98% | 11.09 | 883 / 901 |
| breast | 100% | 2890.13 | 459 / 459 | 97% | 11.54 | 1087 / 1118 |
| brain | 100% | 3313.77 | 2637 / 2642 | 97% | 7.24 | 684 / 705 |
| ovary | 100% | 2888.78 | 180 / 180 | 97% | 8.70 | 416 / 430 |
| pancreas | 98% | 1412.75 | 322 / 328 | 98% | 7.53 | 175 / 178 |
| uterus | 100% | 2663.49 | 170 / 170 | 93% | 6.16 | 427 / 459 |
| esophagus | 100% | 3539.47 | 1445 / 1445 | 93% | 6.14 | 170 / 183 |
| lung | 99% | 2711.94 | 575 / 578 | 92% | 6.29 | 1064 / 1155 |
| bladder | 100% | 3424.76 | 21 / 21 | 91% | 6.01 | 458 / 504 |
| stomach | 100% | 2039.24 | 359 / 359 | 89% | 5.46 | 255 / 286 |
| intestine | 100% | 3434.36 | 966 / 966 | 89% | 5.52 | 468 / 527 |
| adrenal gland | 92% | 1211.88 | 237 / 258 | 89% | 11.38 | 205 / 230 |
| skin | 90% | 1278.07 | 1627 / 1809 | 60% | 3.50 | 281 / 472 |
| liver | 63% | 510.66 | 143 / 226 | 48% | 2.25 | 194 / 406 |
| adipose | 100% | 3082.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 5335.24 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2511.83 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2318.70 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 5.56 | 43 / 45 |
| heart | 95% | 2399.21 | 820 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 4.48 | 24 / 29 |
| peripheral blood | 81% | 4505.72 | 752 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 54% | 2.51 | 43 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006413 | Biological process | translational initiation |
| GO_0006417 | Biological process | regulation of translation |
| GO_0005829 | Cellular component | cytosol |
| GO_0016281 | Cellular component | eukaryotic translation initiation factor 4F complex |
| GO_0003743 | Molecular function | translation initiation factor activity |
| GO_0000340 | Molecular function | RNA 7-methylguanosine cap binding |
| Gene name | EIF4E3 |
| Protein name | Eukaryotic translation initiation factor 4E family member 3 Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3) |
| Synonyms | |
| Description | FUNCTION: Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis. May act as an inhibitor of EIF4E1 activity (By similarity). . |
| Accessions | ENST00000425534.8 [Q8N5X7-1] ENST00000448225.5 [Q8N5X7-2] C9J7Z6 ENST00000497838.5 ENST00000469524.1 ENST00000496214.6 ENST00000421769.6 [Q8N5X7-2] C9J6E5 ENST00000389826.7 [Q8N5X7-2] Q8N5X7 ENST00000295612.7 [Q8N5X7-2] C9JUY2 |
